New pill aims to quiet Alzheimer's psychosis
NCT ID NCT06887192
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This Phase 2 study tests an experimental drug, ML-007C-MA, to see if it can safely reduce hallucinations and delusions in people with Alzheimer's disease. About 300 participants aged 55 to 90 will receive either the drug or a placebo. The main goal is to measure changes in psychotic symptoms using a standard clinician rating scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ML-007C-MA (a combination drug taken as a tablet)
- What this could lead to
- If it works, this could offer a new option to reduce troubling hallucinations and delusions in people with Alzheimer's disease, improving their quality of life.
- What could go wrong
- This is an early Phase 2 trial with only 300 participants, so results may not confirm benefit. The drug may cause side effects or work no better than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Site
RECRUITINGPhoenix, Arizona, 85004, United States
-
Clinical Site
RECRUITINGScottsdale, Arizona, 85253, United States
-
Clinical Site
RECRUITINGTucson, Arizona, 85704, United States
-
Clinical Site
RECRUITINGAnaheim, California, 92805, United States
-
Clinical Site
RECRUITINGMurrieta, California, 92562, United States
-
Clinical Site
RECRUITINGOrange, California, 92866, United States
-
Clinical Site
RECRUITINGSan Diego, California, 92123, United States
-
Clinical Site
RECRUITINGDenver, Colorado, 80218, United States
-
Clinical Site
RECRUITINGBoca Raton, Florida, 33428, United States
-
Clinical Site
RECRUITINGDeerfield Beach, Florida, 33442, United States
-
Clinical Site
RECRUITINGDoral, Florida, 33122, United States
-
Clinical Site
RECRUITINGHomestead, Florida, 33033, United States
-
Clinical Site
RECRUITINGMiami, Florida, 33122, United States
-
Clinical Site
RECRUITINGMiami, Florida, 33155, United States
-
Clinical Site
RECRUITINGMiami, Florida, 33173, United States
-
Clinical Site
RECRUITINGMiami, Florida, 33186, United States
-
Clinical Site
RECRUITINGMiami Gardens, Florida, 33014, United States
-
Clinical Site
RECRUITINGMiami Gardens, Florida, 33104, United States
-
Clinical Site
RECRUITINGNaples, Florida, 34105, United States
-
Clinical Site
RECRUITINGOrlando, Florida, 32807, United States
-
Clinical Site
RECRUITINGTampa, Florida, 33629, United States
-
Clinical Site
RECRUITINGWest Palm Beach, Florida, 33407, United States
-
Clinical Site
RECRUITINGAugusta, Georgia, 30912, United States
-
Clinical Site
RECRUITINGSnellville, Georgia, 30078, United States
-
Clinical Site
RECRUITINGLas Vegas, Nevada, 89121, United States
-
Clinical Site
RECRUITINGWest Long Branch, New Jersey, 07764, United States
-
Clinical Site
RECRUITINGDayton, Ohio, 45459, United States
-
Clinical Site
RECRUITINGIndependence, Ohio, 44131, United States
-
Clinical Site
RECRUITINGMcKinney, Texas, 75071, United States
-
Clinical Site
RECRUITINGSugarland, Texas, 77478, United States
-
Clinical Site
RECRUITINGBellevue, Washington, 98007, United States
-
Clinical Site
RECRUITINGCórdoba, Córdoba Province, X5009BIN, Argentina
-
Clinical Site
RECRUITINGCórdoba, X5004AOA, Argentina
-
Clinical Site
RECRUITINGPernik, Pernik, 2304, Bulgaria
-
Clinical Site
RECRUITINGSofia, Sofia, 1408, Bulgaria
-
Clinical Site
NOT_YET_RECRUITINGBrampton, Ontario, L6W 2Z8, Canada
-
Clinical Site
RECRUITINGLondon, Ontario, N6A 5W9, Canada
-
Clinical Site
RECRUITINGToronto, Ontario, M4N 3M5, Canada
-
Clinical Site
RECRUITINGLévis, Quebec, G6V 0C9, Canada
-
Clinical Site
RECRUITINGChoceň, 565 01, Czechia
-
Clinical Site
RECRUITINGPrague, 150 00, Czechia
-
Clinical Site
RECRUITINGToulouse, 31059, France
-
Clinical Site
RECRUITINGPécs, 7623, Hungary
-
Clinical Site
RECRUITINGPécs, 7633, Hungary
-
Clinical Site
RECRUITINGRoma, 00128, Italy
-
Clinical Site
RECRUITINGPlewiska, 62-064, Poland
-
Clinical Site
RECRUITINGTorres Vedras, Lisbon District, 2560-280, Portugal
-
Clinical Site
RECRUITINGBucharest, 041914, Romania
-
Clinical Site
RECRUITINGKragujevac, 34000, Serbia
-
Clinical Site
RECRUITINGVranov nad Topľou, 093 01, Slovakia
-
Clinical Site
RECRUITINGDaegu, 41404, South Korea
-
Clinical Site
RECRUITINGIncheon, 21565, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for Alzheimer's psychosis: Long-Term drug trial underway
- Could this pill ease Alzheimer's hallucinations?
- New pill aims to calm Alzheimer's psychosis in landmark trial
- New drug KarXT aims to safely treat Alzheimer's psychosis in Long-Term trial
- Hope for Alzheimer's psychosis: new drug aims to stop relapses